Select Page

Latest News

August 20, 2019
Rapid Dose Therapeutics Commences Clinical Research Trial with GI Research Institute and University of British Columbia

August 8, 2019
Rapid Dose Therapeutics and Thrive Cannabis Sign Manufacturing Agreement for Quickstrip™ Cannabis Products

August 1, 2019
Rapid Dose Therapeutics Expands Agreement for Quickstrip™ Nutraceutical Product Line in Eastern Europe and Increases Purchase Order to US$4.0 Million

July 30, 2019
Rapid Dose Reports First Quarter Fiscal 2020 Financial Results and Provides Operations Update

July 25, 2019
Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation at Flower One Resulting in Immediate Revenue Generation

July 16, 2019
Rapid Dose Therapeutics Signs Distribution Agreement for Quickstrip™ Nutraceutical Product Line and Receives US$2.1 Million Purchase Order

June 27, 2019
Rapid Dose Therapeutics and Chemesis to Introduce Innovative Quickstrip™ Oral Thin Strips to the Michigan Cannabis Market

June 13, 2019
Rapid Dose Therapeutics Announces Commercialization of Quickstrip™ Oral Thin Strips

June 6, 2019
Rapid Dose Therapeutics Appoints Vice President, Research & Innovation

April 16, 2019
Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada

1 2 3 4